glp 1 drugs in development GLP-1 Agonists Weight Loss Market Report, 2025-2030 GLP-1 Genetics: How Genes Affect
Description
adult usage of weight-loss medications has more than doubled from 5.8% in early 2024 to 12.4% in 2Q/3Q 2025
doi: 10.1186/1471-2202-13-33 126 ScottLJ
This study further supports the use of these agents in a broad range of people with type 2 diabetes
Tauqeer Z, Bracha P, Hua P, Yu Y, Cui QN, VanderBeek BL
Steroid-induced hyperglycemia successfully treated with once-weekly dulaglutide in an old patient with type 2 diabetes
